Diffuse involvement of the heart and great vessels in primary cardiac lymphoma
dc.contributor.buuauthor | Kaderli, Aysel Aydın | |
dc.contributor.buuauthor | Baran, İbrahim | |
dc.contributor.buuauthor | Aydın, Özlem | |
dc.contributor.buuauthor | Biçer, Murat | |
dc.contributor.buuauthor | Akpınar, Tayyar | |
dc.contributor.buuauthor | Özkalemkaş, Fahir | |
dc.contributor.buuauthor | Yeşilbursa, Dilek | |
dc.contributor.buuauthor | Güllülü, Sümeyye | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kalp ve Damar Cerrahisi Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nükleer Tıp Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | ABC-2231-2020 | tr_TR |
dc.contributor.researcherid | AAG-8495-2021 | tr_TR |
dc.contributor.scopusid | 7801322152 | tr_TR |
dc.contributor.scopusid | 37012019200 | tr_TR |
dc.contributor.scopusid | 57197050271 | tr_TR |
dc.contributor.scopusid | 6507770944 | tr_TR |
dc.contributor.scopusid | 37011914700 | tr_TR |
dc.contributor.scopusid | 6601912387 | tr_TR |
dc.contributor.scopusid | 36658194500 | tr_TR |
dc.contributor.scopusid | 57204660708 | tr_TR |
dc.date.accessioned | 2021-12-30T09:02:38Z | |
dc.date.available | 2021-12-30T09:02:38Z | |
dc.date.issued | 2010-01 | |
dc.description.abstract | Primary cardiac lymphoma (PCL) is an extremely rare disorder. In this report, a 57-year-old male with diffuse large B-cell lymphoma involving the heart and great vessels is presented. Trans-thoracic echocardiography was the first modality used to establish the diagnosis. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) showed diffuse increased metabolic activity of the heart walls and hypermetabolic lesions occupying cardiac chambers in some areas. The patient underwent systemic chemotherapy, and after 13 days, a marked regression of the tumour mass was evident based on echocardiographic examination. After completing six R-CHOP chemotherapy treatments, PET imaging was planned to control the residual mass, but the patient was intubated due to pneumonia that developed after the sixth chemotherapy session and subsequently died due to sepsis. | en_US |
dc.identifier.citation | Kaderli, A. A. vd. (2010). "Diffuse involvement of the heart and great vessels in primary cardiac lymphoma". European Journal of Echocardiography, 11(1), 74-76. | en_US |
dc.identifier.endpage | 76 | tr_TR |
dc.identifier.issn | 1525-2167 | |
dc.identifier.issn | 1532-2114 | |
dc.identifier.issue | 1 | tr_TR |
dc.identifier.pubmed | 19759028 | tr_TR |
dc.identifier.scopus | 2-s2.0-74949094528 | tr_TR |
dc.identifier.startpage | 74 | tr_TR |
dc.identifier.uri | https://doi.org/10.1093/ejechocard/jep111 | |
dc.identifier.uri | https://academic.oup.com/ehjcimaging/article/11/1/74/2396548 | |
dc.identifier.uri | http://hdl.handle.net/11452/23757 | |
dc.identifier.volume | 11 | tr_TR |
dc.identifier.wos | 000273500000011 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ | en_US |
dc.relation.journal | European Journal of Echocardiography | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Primary cardiac lymphoma | en_US |
dc.subject | Echocardiography | en_US |
dc.subject | Positron emission tomography | en_US |
dc.subject | Heart block | en_US |
dc.subject | Immunocompetent patients | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.subject.emtree | Cyclophosphamide | en_US |
dc.subject.emtree | Doxorubicin | en_US |
dc.subject.emtree | Fluorodeoxyglucose f 18 | en_US |
dc.subject.emtree | Prednisolone | en_US |
dc.subject.emtree | Rituximab | en_US |
dc.subject.emtree | Vincristine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Anamnesis | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer chemotherapy | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Computer assisted tomography | en_US |
dc.subject.emtree | Histopathology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Large cell lymphoma | en_US |
dc.subject.emtree | Lymphoma | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Positron emission tomography | en_US |
dc.subject.emtree | Primary cardiac lymphoma | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Transthoracic echocardiography | en_US |
dc.subject.mesh | Antibodies, monoclonal, murine-derived | en_US |
dc.subject.mesh | Antineoplastic combined chemotherapy protocols | en_US |
dc.subject.mesh | Cyclophosphamide | en_US |
dc.subject.mesh | Doxorubicin | en_US |
dc.subject.mesh | Echocardiography | en_US |
dc.subject.mesh | Fatal outcome | en_US |
dc.subject.mesh | Fluorodeoxyglucose F18 | en_US |
dc.subject.mesh | Heart neoplasms | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lymphoma, large B-cell, diffuse | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Pneumonia | en_US |
dc.subject.mesh | Positron-emission tomography | en_US |
dc.subject.mesh | Prednisone | en_US |
dc.subject.mesh | Tomography, X-ray computed | en_US |
dc.subject.mesh | Vincristine | en_US |
dc.subject.scopus | Heart Neoplasms; Angiosarcoma; Myxoma | en_US |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.title | Diffuse involvement of the heart and great vessels in primary cardiac lymphoma | en_US |
dc.type | Article | |
dc.wos.quartile | Q2 | en_US |